Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 1
1975 4
1976 2
1978 1
1979 2
1980 1
1981 3
1982 2
1984 7
1985 3
1986 4
1987 5
1988 3
1989 2
1990 2
1991 1
1992 2
1993 2
1994 1
1996 3
1997 2
2000 3
2001 1
2002 1
2003 1
2004 2
2005 2
2006 1
2009 2
2010 3
2011 2
2013 1
2015 3
2016 4
2017 2
2018 1
2019 2
2020 1
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Among authors: ludwin sk. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. N Engl J Med. 2005. PMID: 15758009 Free article. Clinical Trial.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Among authors: ludwin sk. Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9. Lancet Oncol. 2009. PMID: 19269895 Clinical Trial.
Astrocytes in multiple sclerosis.
Ludwin SK, Rao VTs, Moore CS, Antel JP. Ludwin SK, et al. Mult Scler. 2016 Aug;22(9):1114-24. doi: 10.1177/1352458516643396. Epub 2016 Apr 19. Mult Scler. 2016. PMID: 27207458 Review.
Dilemmas in medical ethics in the age of big data.
Ludwin SK, Murray TJ. Ludwin SK, et al. Mult Scler. 2017 Sep;23(10):1306-1308. doi: 10.1177/1352458517722056. Epub 2017 Jul 26. Mult Scler. 2017. PMID: 28743225 No abstract available.
Immunology of oligodendrocyte precursor cells in vivo and in vitro.
Antel JP, Lin YH, Cui QL, Pernin F, Kennedy TE, Ludwin SK, Healy LM. Antel JP, et al. Among authors: ludwin sk. J Neuroimmunol. 2019 Jun 15;331:28-35. doi: 10.1016/j.jneuroim.2018.03.006. Epub 2018 Mar 13. J Neuroimmunol. 2019. PMID: 29566973 Review.
The reactions of the oligodendrocyte.
Ludwin SK. Ludwin SK. Mult Scler. 1996 Dec;2(5):241-3. doi: 10.1177/135245859600200507. Mult Scler. 1996. PMID: 9050363 Review. No abstract available.
The pathobiology of the oligodendrocyte.
Ludwin SK. Ludwin SK. J Neuropathol Exp Neurol. 1997 Feb;56(2):111-24. doi: 10.1097/00005072-199702000-00001. J Neuropathol Exp Neurol. 1997. PMID: 9034364 Review. No abstract available.
86 results